NO20044051L - Analyse for ACTRIIB-kinase aktivitet - Google Patents

Analyse for ACTRIIB-kinase aktivitet

Info

Publication number
NO20044051L
NO20044051L NO20044051A NO20044051A NO20044051L NO 20044051 L NO20044051 L NO 20044051L NO 20044051 A NO20044051 A NO 20044051A NO 20044051 A NO20044051 A NO 20044051A NO 20044051 L NO20044051 L NO 20044051L
Authority
NO
Norway
Prior art keywords
assay
kinase activity
actriib
activity
actriib kinase
Prior art date
Application number
NO20044051A
Other languages
English (en)
Inventor
Philip Albert Krasney
Michael Norcia
Barbara Ann O'connor
Robin Whitney Spencer
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20044051L publication Critical patent/NO20044051L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G01N2333/91215—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår kinase analyser, og spesielt nye kinase analysemetoder som anvender et nytt mål-peptid for måling av aktiviteten og/eller modulering av aktiviteten av ActRliB-kinaseproteinet.
NO20044051A 2002-02-28 2004-09-24 Analyse for ACTRIIB-kinase aktivitet NO20044051L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36060702P 2002-02-28 2002-02-28
PCT/IB2003/000638 WO2003072808A1 (en) 2002-02-28 2003-02-17 Assay for activity of the actriib kinase

Publications (1)

Publication Number Publication Date
NO20044051L true NO20044051L (no) 2004-09-24

Family

ID=27734775

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044051A NO20044051L (no) 2002-02-28 2004-09-24 Analyse for ACTRIIB-kinase aktivitet

Country Status (12)

Country Link
US (1) US20030219846A1 (no)
EP (1) EP1340817A1 (no)
JP (1) JP2003250537A (no)
KR (1) KR20040084942A (no)
CN (1) CN1643161A (no)
AU (1) AU2003206033A1 (no)
CA (1) CA2476942A1 (no)
HR (1) HRP20040786A2 (no)
IL (1) IL163658A0 (no)
NO (1) NO20044051L (no)
RU (1) RU2004126254A (no)
WO (1) WO2003072808A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060127043A (ko) * 2003-12-22 2006-12-11 알콘, 인코퍼레이티드 녹내장성 망막병증 및 시각신경병증의 치료용 약제
JP2007515422A (ja) * 2003-12-22 2007-06-14 アルコン，インコーポレイテッド 糖尿病性網膜症および黄斑変性における結晶腔形成の処置のための薬剤
TW200526224A (en) * 2003-12-22 2005-08-16 Alcon Inc Short form c-Maf transcription factor antagonists for treatment of glaucoma
US20080096238A1 (en) * 2004-03-30 2008-04-24 Alcon, Inc. High throughput assay for human rho kinase activity with enhanced signal-to-noise ratio
WO2005102345A1 (en) * 2004-03-30 2005-11-03 Alcon, Inc. Use of rho kinase inhibitors in the treatment of hearing loss, tinnitus and improving body balance
US20060115870A1 (en) * 2004-03-30 2006-06-01 Alcon, Inc. High throughput assay for human Rho kinase activity
ES2426005T3 (es) 2004-07-23 2013-10-18 Acceleron Pharma Inc. Polipéptidos del receptor ACTRII, procedimientos y composiciones
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
AU2006318449B2 (en) 2005-11-23 2012-07-05 Acceleron Pharma Inc. Activin-actRIIa antagonists and uses for promoting bone growth
CN104524548A (zh) * 2006-12-18 2015-04-22 阿塞勒隆制药公司 活化素-actrii拮抗剂及在提高红细胞水平中的用途
US8895016B2 (en) 2006-12-18 2014-11-25 Acceleron Pharma, Inc. Antagonists of activin-actriia and uses for increasing red blood cell levels
CA2677007A1 (en) 2007-02-01 2008-08-07 Acceleron Pharma Inc. Activin-actriia antagonists and uses for treating or preventing breast cancer
TWI782836B (zh) 2007-02-02 2022-11-01 美商艾瑟勒朗法瑪公司 衍生自ActRIIB的變體與其用途
TWI667038B (zh) 2007-02-09 2019-08-01 美商艾瑟勒朗法瑪公司 包含ＡｃｔＲＩＩａ-Ｆｃ融合蛋白的醫藥組合物；ＡｃｔＲＩＩａ-Ｆｃ融合蛋白於治療或預防與癌症相關的骨質流失之用途；ＡｃｔＲＩＩａ-Ｆｃ融合蛋白於治療或預防多發性骨髓瘤之用途
US7960343B2 (en) 2007-09-18 2011-06-14 Acceleron Pharma Inc. Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
SI3750552T1 (sl) 2008-08-14 2023-10-30 Acceleron Pharma Inc. GDF pasti
CA2749544A1 (en) * 2009-01-13 2010-07-22 Acceleron Pharma Inc. Methods for increasing adiponectin
EP3845239A1 (en) 2009-06-08 2021-07-07 Acceleron Pharma Inc. Use of anti-actriib proteins for increasing thermogenic adipocytes
CN107267520A (zh) 2009-06-12 2017-10-20 阿塞勒隆制药公司 截短的actriib‑fc融合蛋白
US8710016B2 (en) 2009-11-17 2014-04-29 Acceleron Pharma, Inc. ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
CN103298832A (zh) 2010-11-08 2013-09-11 阿塞勒隆制药公司 Actriia结合剂及其用途
WO2014030683A1 (ja) * 2012-08-21 2014-02-27 国立大学法人九州大学 貧血患者の貧血の要因を検出するためのバイオマーカー
CA2890217C (en) 2012-11-02 2021-07-20 Yifu FANG Activin-actrii antagonists and uses for treating bone and other disorders
WO2015192111A1 (en) 2014-06-13 2015-12-17 Acceleron Pharma, Inc. Methods and compositions for treating ulcers
MA41052A (fr) 2014-10-09 2017-08-15 Celgene Corp Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
BR112017011722A2 (pt) 2014-12-03 2018-02-27 Acceleron Pharma Inc antagonistas de activina-actrii e usos para o tratamento de anemia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6059099A (en) * 1998-09-25 2000-04-17 Children's Medical Center Corporation Short peptides which selectively modulate the activity of protein kinases
GB9923208D0 (en) * 1999-10-01 1999-12-08 Cambridge Drug Discovery Ltd Assay
US20020115173A1 (en) * 2000-12-11 2002-08-22 Children's Medical Center Corporation Short peptides from the 'A-region' of protein kinases which selectively modulate protein kinase activity
AUPR638101A0 (en) * 2001-07-13 2001-08-09 Bioa Pty Limited Composition and method for treatment of disease
US20040223966A1 (en) * 2002-10-25 2004-11-11 Wolfman Neil M. ActRIIB fusion polypeptides and uses therefor

Also Published As

Publication number Publication date
US20030219846A1 (en) 2003-11-27
WO2003072808A1 (en) 2003-09-04
EP1340817A1 (en) 2003-09-03
HRP20040786A2 (en) 2004-12-31
KR20040084942A (ko) 2004-10-06
CA2476942A1 (en) 2003-09-04
AU2003206033A1 (en) 2003-09-09
CN1643161A (zh) 2005-07-20
IL163658A0 (en) 2005-12-18
JP2003250537A (ja) 2003-09-09
RU2004126254A (ru) 2005-04-10

Similar Documents

Publication Publication Date Title
NO20044051L (no) Analyse for ACTRIIB-kinase aktivitet
HUP0200400A2 (hu) Fehérjék izolálása és elemzése
ATE530644T1 (de) Protease-screening-verfahren und dadurch identifizierte proteasen
DK1454992T3 (da) Anaplastisk lymfomakinaseassay, reagenser og sammensætninger deraf
ATE464374T1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
DE60330376D1 (de) Defructosylierungsverfahren
BRPI0617788A2 (pt) processos isolados estaticamente verificáveis com comunicação interprocessos
WO2005010215A3 (en) Methods for identifying tolerance modulatory compounds and uses therefor
EA200702193A1 (ru) Гликозилирование белков
NO20064715L (no) Deteksjon, isolering og anvendelse av renalase (monoamin aksidase C)
WO2007067983A3 (en) Sulfotyrosine specific antibodies and uses therefor
NO20062015L (no) Anti-NIK-antistoffer og anvendelser derav
DK1485481T3 (da) Fflourescerende protein fra Aequorea Coerulescens og anvendelser deraf
ES2185652T3 (es) Oligopeptidos derivados de fragmentos de proteinas c-reactiva.
ATE498018T1 (de) Nachweis von salmonella-lactose+
ATE412187T1 (de) Screening test
DE602005015108D1 (de) Methode für die Analyse von Substanzen gegen Flaviviren unter Verwendung eines persistent Virus-infizierten Zellsystems
DE502006005985D1 (de) Testsystem zum nachweis von salmonellen
BR0308321A (pt) Inibidores da peptìdeo deformilase
FR2840409B1 (fr) Dispositif de presentation de peptides ou de proteines, son procede de preparation et ses utilisations
WO2005001133A3 (en) Compositions and methods for high throughput construction and functional analysis of expression libraries
WO2007048830A3 (en) Assays for histone deacetylase 1/2 selective inhibitors
NO20043330L (no) Assay for deteksjon av faktorer som modulerer ekspresjon av INGAP
DE60302764D1 (de) Test auf phosphoamidase
WO2005015154A3 (en) Autocatalysis/yeast two-hybrid assay

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application